Outpatient Posterior Cervical Fusion: Outcomes of the First 100 Consecutive Cases
Outpatient Posterior Cervical Decompression, Instrumentation, and Fusion: The First Consecutive 100 Cases
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Neenah, Wisconsin, United States, 54956
- NeuroSpine Center of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients with neurological signs and symptoms related to cervical stenosis, confirmed by MRI, who have failed to improve with appropriate conservative management.
Exclusion Criteria:
- patients who represent an inordinate risk to undergo general anesthesia in the outpatient setting.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Posterior Cervical Decompression, Instrumentation and Fusion Patients
100 consecutive patients with documented cervical spinal cord and/or nerve root compression unresponsive to conservative management.
|
This is the only study evaluating OUTPATIENT posterior cervical decompression, instrumentation, and fusion patients in a prospective fashion with a median follow-up of 2.5 years.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurologic Function (Modified JOA Score)
Time Frame: Baseline and 3 months post-operative
|
Neurologic status will be assessed using the Modified Japanese Orthopaedic Association (mJOA) Score (1-18), with higher scores indicating better neurologic function.
|
Baseline and 3 months post-operative
|
|
Myelopathy Severity (Nurick Grade)
Time Frame: Baseline and 3 months post-operative
|
Myelopathy severity will be measured using the Nurick Scale (Grades 0-5), with higher grades indicating greater impairment.
|
Baseline and 3 months post-operative
|
|
Pain Severity (VAS Neck and Arm Pain Scores)
Time Frame: Baseline, 3 months post-operative, and final follow-up (average 5 years)
|
Pain will be assessed using the Visual Analog Scale (VAS) for neck and arm pain (0-10).
|
Baseline, 3 months post-operative, and final follow-up (average 5 years)
|
|
Functional Disability (Oswestry Neck Pain Index)
Time Frame: Baseline and 3 months post-operative
|
Functional impairment will be assessed using the Oswestry Neck Pain Index (0-100%).
|
Baseline and 3 months post-operative
|
|
Surgical Outcome Rating (Odom Criteria)
Time Frame: 3 months post-operative and extended follow-up (average 5 years)
|
Patient-reported surgical outcome will be graded using Odom Criteria (Excellent, Good, Fair, Poor).
|
3 months post-operative and extended follow-up (average 5 years)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Postoperative Complications or Readmissions
Time Frame: Day of surgery through study completion (average 5 years)
|
All postoperative medical and surgical complications-including ER visits, unplanned admissions, and reoperations-will be recorded.
|
Day of surgery through study completion (average 5 years)
|
|
Number of Participants With Radiographic Evidence of Fusion or Hardware Failure
Time Frame: 6 weeks, 3 months, and extended follow-up (average 5 years)
|
Radiographic evaluation of fusion status, hardware failure, and pseudoarthrosis will be performed using AP/lateral and flexion-extension cervical spine radiographs.
|
6 weeks, 3 months, and extended follow-up (average 5 years)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- TMW-2025-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.